SCHEMBL15219237

SCHEMBL15219237

C[C@H](I)O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD2 Q9NRG4 2/20 0.34
CYP3A4 P08684 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
RIPK1 Q13546 1/20 0.32
AOC3 Q16853 1/20 0.31
CACNA1F O60840 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
ADRA2B P18089 1/20 0.31
CHRM3 P20309 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
OPRK1 P41145 1/20 0.31
CACNA1D Q01668 1/20 0.31
SLC6A3 Q01959 1/20 0.31
KCNH2 Q12809 1/20 0.31
CACNA1S Q13698 1/20 0.31
CACNA1C Q13936 1/20 0.31
SCN5A Q14524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9232886 1.00 SMYD2 (0.34) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL16147772 0.85 CYP3A4 (0.32) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL5026307 0.85 CYP3A4 (0.32) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL705925 0.84 RIPK1 (0.34) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL7503724 0.81 ALDH1A1 (0.38) CYP3A4HTTSMN1; SMN2AOC3SLC6A3
SCHEMBL29086735 0.81 CYP3A4 (0.33) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL7354376 0.81 CYP3A4 (0.33) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL17491817 0.81 ALDH1A1 (0.38) RIPK1AOC3SLC6A3SLC6A4ALDH1A1
SCHEMBL28549734 0.81 CYP3A4 (0.33) SMYD2CYP3A4HTTSMN1; SMN2RIPK1
SCHEMBL19513655 0.81 CYP3A4 (0.33) SMYD2CYP3A4HTTSMN1; SMN2RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013124826-A1 OXAZOLIDIN- 2 -ONE COMPOUNDS AND USES THEREOF AS PI3KS INHIBITORS NOVARTIS AG (CH) 2013-08-29 WO disclosed